Eva Dokoupilova

Eva Dokoupilova

UNVERIFIED PROFILE

Are you Eva Dokoupilova?   Register this Author

Register author
Eva Dokoupilova

Eva Dokoupilova

Publications by authors named "Eva Dokoupilova"

Are you Eva Dokoupilova?   Register this Author

17Publications

951Reads

35Profile Views

Efficacy and Safety of Anti-Interleukin-20 Monoclonal Antibody in Patients With Rheumatoid Arthritis: A Randomized Phase IIa Trial.

Arthritis Rheumatol 2015 Jun;67(6):1438-48

Hospital Clinic de Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.39083DOI Listing
June 2015

One-year efficacy and safety results of secukinumab in patients with rheumatoid arthritis: phase II, dose-finding, double-blind, randomized, placebo-controlled study.

J Rheumatol 2014 Mar 15;41(3):414-21. Epub 2014 Jan 15.

From Stanford University, Palo Alto, California, USA; Pôle de Recherche en Rhumatologie, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain and Cliniques Universitaires Saint-Luc, Brussels, Belgium; Novartis Pharma AG, Basel, Switzerland; NZOZ Centrum Medyczne Artur Racewicz, Bialystok, Poland; Medical Plus, Uherske Hradiste, Czech Republic; Arthritis Clinic, Jackson, Tennessee, USA; Konkuk University Medical Center, Seoul, South Korea; Health Research of Oklahoma, Oklahoma City, Oklahoma, USA; Centre for Inflammatory Joint Diseases, Munich, Germany; Kobe-Konan Yamate Clinic, Kobe, Japan; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.130637DOI Listing
March 2014